209799-75-7 Usage
Uses
Used in Pharmaceutical Industry:
4H-Pyrrolo3,2-dpyrimidin-4-one, 2-amino-7-(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-pyrrolidinyl-1,5-dihydrois used as a potential therapeutic agent for various diseases due to its unique molecular structure and biological activities.
Used in Antiviral Applications:
In the field of antiviral research, 4H-Pyrrolo3,2-dpyrimidin-4-one, 2-amino-7-(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-pyrrolidinyl-1,5-dihydro- may be used as a potential antiviral agent, similar to Immucillin-G, a 9-deazanucleoside analog with antiviral, antibacterial, and antimalarial properties. The specific antiviral activity of 4H-Pyrrolo3,2-dpyrimidin-4-one, 2-amino-7-(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-pyrrolidinyl-1,5-dihydrowould depend on its ability to target and inhibit viral replication mechanisms.
Used in Antibacterial Applications:
The compound may also be explored for its potential antibacterial properties, contributing to the development of new antibiotics to combat drug-resistant bacterial infections.
Used in Antimalarial Applications:
Similar to its potential antiviral and antibacterial applications, 4H-Pyrrolo3,2-dpyrimidin-4-one, 2-amino-7-(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-pyrrolidinyl-1,5-dihydrocould be investigated for its effectiveness against malaria-causing parasites, providing a new avenue for antimalarial drug development.
Used in Drug Delivery Systems:
In the field of drug delivery, 4H-Pyrrolo3,2-dpyrimidin-4-one, 2-amino-7-(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-pyrrolidinyl-1,5-dihydro- could be utilized as a component in the design of novel drug delivery systems, potentially enhancing the bioavailability, targeting, and overall efficacy of various therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 209799-75-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,9,7,9 and 9 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 209799-75:
(8*2)+(7*0)+(6*9)+(5*7)+(4*9)+(3*9)+(2*7)+(1*5)=187
187 % 10 = 7
So 209799-75-7 is a valid CAS Registry Number.
209799-75-7Relevant academic research and scientific papers
Inhibitors of nucleoside metabolism
-
, (2008/06/13)
The present invention provides compounds having the formula: wherein A is CH or N; B is chosen from OH, NH2, NHR, H or halogen; D is chosen from OH, NH2, NHR, H, halogen or SCH3; R is an optionally substituted alkyl, aralkyl or aryl group; and X and Y are independently selected from H, OH or halogen except that when one of X and Y is hydroxy or halogen, the other is hydrogen; and Z is OH or, when X is hydroxy, Z is selected from hydrogen, halogen, hydroxy, SQ or OQ, Q is an optionally substituted alkyl, aralkyl or aryl group; or a tautomer thereof; or a pharmaceutically acceptable salt thereof; or an ester thereof; or a prodrug thereof; and compounds having the formula: wherein A, X, Y, Z and R are defined for compounds of formula (I) where first shown above; E is chosen from CO2H or a corresponding salt form, CO2R, CN, CONH2, CONHR or CONR2; and G is chosen from NH2, NHCOR, NHCONHR or NHCSNHR; or a tautomer thereof, or a pharmaceutically acceptable salt thereof, or an ester thereof, or a prodrug thereof. The present invention also provides the use of the above compounds as pharmaceuticals, pharmaceutical compositions containing the compounds and processes for preparing the compounds.
Inhibitors of nucleoside metabolism
-
, (2008/06/13)
The present invention provides compounds having the formula: STR1 wherein A is CH or N; B is chosen from OH, NH2, NHR, H or halogen; D is chosen from OH, NH2, NHR, H, halogen or SCH3 ; R is an optionally substituted alkyl, aralkyl or aryl group; and X and Y are independently selected from H, OH or halogen except that when one of X and Y is hydroxy or halogen, the other is hydrogen; and Z is OH or, when X is hydroxy, Z is selected from hydrogen, halogen, hydroxy, SQ or OQ, Q is an optionally substituted alkyl, aralkyl or aryl group; or a tautomer thereof; or a pharmaceutically acceptable salt thereof; or an ester thereof; or a prodrug thereof. The present invention also provides the use of these compounds as pharmaceuticals, pharmaceutical compositions containing the compounds and processes for preparing the compounds.
